Skip to content
Home » Archives for vittoria.majocchi@smm-srl.it

vittoria.majocchi@smm-srl.it

Rottapharm Biotech announces upcoming oral presentation of CR10049 in the inflammatory osteoarthritis (OA) phenotype at the OARSI World Congress on OA

  • News

Press Release Presentation April 11, 2024 Monza (Italy) – Rottapharm Biotech, a research company dedicated to the discovery and development of innovative drugs, today announces that… Read More »Rottapharm Biotech announces upcoming oral presentation of CR10049 in the inflammatory osteoarthritis (OA) phenotype at the OARSI World Congress on OA